Protalix Biotherapeutics, Inc. (PLX)
1.98
+0.02
(+1.02%)
USD |
NYAM |
Jun 09, 12:52
Protalix Biotherapeutics Price : 1.98 for June 9, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Agenus, Inc. | 3.15 |
| Altimmune, Inc. | 2.62 |
| Humacyte, Inc. | 1.34 |
| Amgen, Inc. | 346.10 |
| BioCryst Pharmaceuticals, Inc. | 8.425 |
Price Related Metrics
| PE Ratio | 10.80 |
| PS Ratio | 2.110 |
| PEG Ratio | 0.0321 |
| Price to Book Value | 2.373 |
| Price to Free Cash Flow | 12.40 |
| Earnings Yield | 9.26% |
| Market Cap | 159.53M |
| PEGY Ratio | 0.0321 |
| Operating PE Ratio | 8.143 |
| Normalized PE Ratio | 10.80 |